White Coat, Masked Hypertensives Could Win Ambulatory Blood Pressure Monitoring Coverage Under CMS Proposal
An April 9 proposed decision memo from the US Centers for Medicare and Medicaid Services would allow additional coverage for use of ambulatory blood pressure monitoring (APBM) devices by Medicare beneficiaries with known or suspected high blood pressure who meet specific criteria defined by the agency.
You may also be interested in...
The US Medicare agency has decided that evidence is sufficient to cover ambulatory blood pressure monitoring to help diagnose hypertension in beneficiaries who suffer from white coat high blood pressure, and those with suspected masked hypertension.
The agency is reopening the coverage policy on ambulatory blood pressure monitoring, non-invasive blood pressure measurement over 24-hour cycles, in response to a request from medical professional societies. Currently, Medicare only covers ABPM in limited circumstances where there is reason to believe a patient's in-office blood-pressure is not an accurate representation of their normal blood pressure.
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.